Program-at-a-Glance

MIXiii Biomed 2017 Program-at-a-Glance

Note: Lecture times highlighted in light blue indicate company presentations.

Please check program on site for last minute changes. PRINTABLE VERSION(pdf)


	TUESDAY MAY 23, 2017
07:30 – 17:00	Registration Open
09:15 – 09:40	Welcome by Conference Co-Chairpersons Ruti Alon, Founder & CEO, Medstrada Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners
09:40 – 10:00	Nechemia (Chemi) J. Peres, Managing General Partner and Co-Founder of Pitango: "Special Tribute to Mr. Shimon Peres"
10:00 – 10:50	Shmuel (Mooly) Eden, Former Intel Senior Vice President and President Intel Israel, Chairman, University of Haifa: "The exponential world, can we improve the quality of life of the elderly"
10:50 – 11:20	Coffee Break
	PERSONAL DIAGNOSTICS AND PERSONAL MEDICINE HALL A		NEURODEGENERATIVE DISEASES HALL B		THE IMPACT OF AGING ON POPULATION HEALTH AND WORLD ECONOMY HALL C
	Symposium Chairperson: Dr. Iris Grossman, PhD, Vice President, Teva Pharmaceuticals		Symposium Chairperson: Prof. Nir Giladi, MD, Tel Aviv Medical Center, Ichilov Hospital		Symposium Chairperson: Prof. Shlomo Noy, MD, PhD, Sheba Medical Center
	11:20 - 11:40	Eran Eden, PhD, CEO MEMed Ltd.: "Challenges and opportunities of developing new personalized Dx Product"	11:20 - 11:50	Prof. Nir Giladi, MD, Tel Aviv Medical Center, Ichilov Hospital: "The road to early detection and prevention of neurodegeneration"	11:20 - 11:45	Prof. Shlomo Noy, MD, PhD, Sheba Medical Center: "The impact of aging population on health technologies and economy"
	11:40 - 12:10	Yarmela Pavlovic and Randy J. Prebula, Hogan Lovells: "Precision Medicine: Companion & Complementary Diagnostics"	11:50 - 12:10	Tami Rachmilewitz, Medical Director, Neuroderm: "State that matters: The story of liquid levodopa"	11:45 - 12:15	Stephen A. Kagan, MD, FACP, Healthy Ageing Center of Excellence; Senior Director, Rare Disease, Global Medical Affairs, Pfizer, Inc.: “Framing Our Work Around a Platform of Healthy Ageing”
	12:10 - 12:25	Dekel Taliaz, Taliaz Ltd.: "AlgoSight Antidepressant - selecting the right treatment for people suffering from depression"	12:10 - 12:25	Yoram Solberg, BrainsGate Ltd: "BrainsGate - Spheno Palatine Ganglion (SPG) Stimulation to Treat Acute Ischemic Stroke"	12:15 - 12:30	Assaf Sella, Kytera Technologies LTD: "A New Paradigm For Aging In Place"
	12:25 - 12:40	Moti Gal, NovellusDx "NovellusDx Functional Oncology Diagnostics"	12:25 - 12:40	Eyal Baror, Neuronix Ltd.: "Neuronix Technology for Treatment of Alzheimer's disease - Results of Phase-III US Multi-Center Study"	12:30 - 12:45	Yaron Tal, ChroniSense Medical, Ltd.: "ChroniSense"
	12:40 - 13:00	Prof. Yuval Dor, PhD, The Hebrew University of Jerusalem: "Noninvasive detection of cell death"	12:40 - 13:00	Prof. Michal Beeri, PhD, Sheba Medical Center: Neurodegeneration: "An economic, societal and emotional disaster and the role of brain technologies as the light at the end of the tunnel"	12:45 - 13:00	Avner Halperin, EarlySense: "Democratizing Healthcare: Empowering Proactive Care at Home"
	13:00 - 13:20	Prof. Gal Markel, MD, PhD, Sheba Medical Center: "Biomarkers for immune checkpoint inhibitors"	13:00 - 13:20	Dr. Shahar Arzy, MD, PhD, Hadassah Medical Center: "Clara: a new tool for early identification of the core disorder in Alzheimer's disease"	13:00 - 13:20	Prof. Tzvi Dwolatzky, MD, MBBCh, Rambam Medical Center: "Frontiers in Medicine: New Leadership for Geriatric Medicine"
13:20 - 14:50	Lunch Break
	14:50 - 15:15	Dr. Mark D. Stovsky, MD, MBA, FACS, Senior Director, Emerging Business, Cleveland Clinic Ventures and Cleveland Clinic Innovations: "Innovations in Cancer Diagnostics from the Cleveland Clinic"	14:50 - 15:15	David Simon, PhD, Medtronic, RTG Brain Therapies Neurosurgery: "Medtronic Brain Therapies: Achieving our Inorganic Growth Aspirations"	14:50 - 15:05	Rami Cohen, Telesofia Medical: "Personalized videos for the elderly"
	15:15 - 15:35	Dr. Iris Grossman, PhD, Vice President, Teva Pharmaceuticals: "Harnessing biomarkers and digital markers to holistically address the individual's needs to maintain health in later decades of life"	15:15 - 15:35	Dr. Ilana Schlesinger, MD, Rambam Medical Center: "Essential tremor and Parkinson's - frontiers of therapeutics (Insightec)"	15:05 - 15:20	Omri Shor, Medisafe: "5 Guiding Principles for Sustained Patient Engagement in Medication Adherence"
	15:35 - 15:50	Yael Glickman, Micromedic Technologies Ltd: "Innovative diagnostic platform for early cancer detection"	15:35 - 15:50	Yuval Mor, Beyond Verbal Communication Ltd.: "Using AI to Revolutionize Healthcare"	15:20 - 15:45	Ziv Ofek, Founder and CEO, CDI (Center for Digital Innovation): "Healthy Aging: when challenges meet Innovation"
	15:50 - 16:05	Assaf Oron, BiomX: "Modulating the microbiome to develop noveltherapeutics - an emerging field "	15:50 - 16:05	Son Preminger, Intendu: "Intendu Active Brain Trainer - Transforming Brain Health in Aging and following Injury and Disease"	15:45 - 17:15	START-UP COMPETITION
	16:05 - 16:20	Dr. Elon Ganor, Nucleix: "Nucleix – Using Epigenetics for Cancer Detection in Liquid Biopsy"	16:05 - 16:25	Prof. Shai Efrati, MD, Sagol Center for Hyperbaric Medicine and Research: "Hyperbaric treatment for cognitive health"
	16:20 - 16:45	Ben Newton, GE Healthcare Life Sciences: "Biomarkers development and production in the Molecular Imaging arena: GE perspective and strategy"	16:25 - 17:25	Panel: Discussion & Conclusion
	16:45 - 17:45	Panel: Discussion & Conclusion
17:45 – 19:45	Gala Event

	WEDNESDAY, MAY 24, 2017
08:00 – 16:00	Registration Open
09:00 - 09:45	Deborah DiSanzo, General Manager, IBM Watson Health: : "Changing Health through the Power of Cognitive"
09:45- 10:30	Dr. Gil Bar Nahum, PhD, Managing Director at Jefferies International: "Life Science industries and Markets: Past, Present and Future"
10:30 - 11:20	PANEL: Healthcare Investment 2017: Essential Thoughts from Leading Investors, Bankers and Strategic Partners on the Rapidly Evolving Sector Moderator: Ron Ginor, MD, Venture Partner, Orbimed Participants: Andrew ElBardissi, MD, Investor, Deerfield Management, San Francisco, USA Eric Tansky, Managing Director, Healthcare Investment Banking Group, Wedbush, New York, USA Stuart Barich, Managing Director, Healthcare Banking Group, Raymond James, New York, USA Kelly Krajnik, Business Development, Mayo Clinic Ventures, Rochester, Minnesota, USA
11:20 - 11:50	Coffee Break
	DIGITAL HEALTH FOR THE ELDERLY HALL A		REGENERATIVE AND CELL THERAPIES HALL B		ROBOTICS ROLE IN AGING HALL C
	Symposium Chairperson: Sharon Shapira, Digital Health Program Manager, Startup Nation Central		Symposium Chairpersons: Ora Dar, PhD, Israel Innovation Authority Zami Aberman, CEO Pluristem Therapeutics Inc.		Symposium Chairperson: Prof. Tamar Flash, Weizmann Institute
	11:50 - 12:20	Rutie Adar, Director, Head of Samsung Strategy and Innovation Center:	11:50 - 11:55	Can Cell Based Regenerative Treatments Cure Age Related Diseases? Keynote speakers:	11:50 - 12:15	Prof. Filippo Cavallo, PhD, The BioRobotics Institute, Scuola Superiore Sant'Anna: "Companion robotics for active and healthy ageing and their caregivers"
	12:20 - 12:50	Antonio (Tony) Estrella, Managing Partner, Head of Health Innovation at LumenLab, MetLife Innovation Centre, Singapore:	11:55 - 12:15	Prof. Steven E. Cohen, MD, Daiichi Sankyo, Inc.: ”Cell Based Regenerative Treatments for Cardiovascular-Metabolism & Internal Medicine - DSI strategy and implementation”	12:15 - 12:30	Dr. Amit Goffer, PhD, UPnRIDE Robotics Ltd.
	12:50 - 13:20	Sudipto Srivastava, Senior Director, eHealth at Mount Sinai Health System, USA:	12:15 - 12:30	Prof. Benjamin Reubinoff, MD, PhD, Hadassah Medical Center: "Human embryonic stem cell- transplantation therapy in AMD patients (CellCure)"	12:30 - 12:50	Prof. Gal A. Kaminka, PhD, Bar-Ilan University: "Many for One for Many: Challenges for artificial intelligence and robotics"
	13:20 - 13:35	Gal Salomon, Intensix: "Predictive Critical Care"	12:30 -12:45	Esther Lukasiewics Hagai, MD, PhD, Pluristem Ltd.: ”Advanced (Phase III) cell therapy clinical studies for Critical Limb Ischemia and age related muscle injury”	12:50 - 13:10	Prof. Alon Wolf, PhD., Technion Institute of Technology: "From Biomechanics to Biorobotics - Confronting Aging"
	13:35 - 13:50	Eliran Malki, Belong: "Belong - Treatment Journey Optimization Company"	12:45 - 13:00	Yael Margolin, PhD, Gamida: "Enabling the possibility of bone marrow transplantation for practically all patients in need"	13:10 - 13:35	Dr. Maja Rudinac, PhD, CEO, Robot Care Systems, Netherlands: "Towards design of the care of the future: LEA – The Lean Empowering Assistant"
			13:00 - 13:50	Panel discussion: Challenges in clinical development of Cell Based Treatments Moderator: Ora Dar, PhD, Israel Innovation Authority Participants: Prof. Steven E. Cohen, MD, Daiichi Sankyo, Inc. Jane Andrews, PhD, Senior Consultant, Transformational Health & Lifesciences, North America Frost & Sullivan Prof. Benjamin Reubinoff, MD, PhD, Hadassah Medical Center Yael Margolin, PhD, Gamida Esther Lukasiewics Hagai, MD, PhD, Pluristem Ltd	13:35 - 13:50	Reuven Granot, PhD, Perlis Ltd: "Early Detection of Frail Elderly Symptoms"
	Lunch Break
	15:20 - 15:35	Michal Devir, Pro IV Medical (HOME TRAX): "On line data & Real time monitoring of patients recieveing infusion therapy"	15:20 - 15:25	Financing Regenerative cell based Medicine: investment approaches in cell therapy Keynote Speakers:	15:20 -15:35	Dor Skuler, CEO, Intuition Robotics:
	15:35 - 15:50	Ziv Yekutieli, Montfort Brain Monitor: "Neurological tests in the 21st century - mind the gap!"	15:25 - 15:45	Jane Andrews, PhD, Senior Consultant, Transformational Health & Lifesciences, North America Frost & Sullivan: "Cell Therapy - The Race to Market: Funding, Regulatory, Business models and Marketing"	15:35 - 15:55	Prof. Tamar Weiss, PhD, University of Haifa: "Why haven't robotics achieved disruption for the elderly"
	15:50 - 16:05	Elad Fein, iFeel Healthy: "iFeel 's respiratory digital therapy to monitor and prevent pulmonary exacerbation"	15:45 - 16:00	Jim Knight, BioTime, Inc. ”BioTime - evolution of company - the financing challenge”	15:55 - 16:15	Prof. Dario Liebermann, PhD, Sackler Faculty of Medicine, Tel Aviv University: "Movement deterioration with age and robot-based motor function preservation"
	16:05 - 16:20	Liza Futerman, Arts For Dementia: "Culture Change in Dementia Care in Israel and Worldwide"	16:00 - 16:15	Yael Gothelf, BrainSTorm-Cell Therapeutics Ltd.: "Safety and efficacy of transplantation of NurOwn (Autologous Mesenchymal Stromal Cells secreting Neurotrophic factors) in patients with ALS: a Phase 2 randomized double blind placebo controlled study"	16:15 - 16:30	Chen Levin, XACT Robotics Ltd: "XACT Robotics - Image Guided Robotic Steering"
	16:20 - 16:35	Eyal Greenberg, 2bPrecise: "Injecting Genomic interventions into the clinical workflow - Challenges and Solutions"	16:15 - 16:30	Michal Izrael, Kadimastem Ltd.: "Kadimastem's cell therapy product for the treatment of Amyotrophic Lateral Sclerosis (ALS): Progression towards clinical trials in 2017"	16:30 - 17:30	Robotics Panel Moderator: Prof. Tamar Flash, Weizmann Institute Paul Hermes, Entrepreneur in Residence Surgical Innovations, Medtronic Prof. Yael Edan, PhD, Ben Gurion University of the Negev Prof. Sigal Berman, PhD, Ben Gurion University of the Negev Dr. Yael Sorek-Benvenisti, Chairperson, Technologies of Aging Well
	16:35 - 17:35	Panel: Technology and The Elderly People Moderator: Prof. Eugene Kandel, CEO, Startup Nation Central Participants: Allen Kamer, Managing Partner, OurCrowd Qure Rutie Adar, Director, Head of Samsung Strategy and Innovation Center Antonio (Tony) Estrella, Managing Partner, Head of Health Innovation at LumenLab, MetLife Innovation Centre Sudipto Srivastava, Senior Director, eHealth at Mount Sinai Health System, USA Assaf Sella, Kytera Technologies	16:30 -16:45	Prof. Moshe Flugelman, Vessl Therapy:"Vessl therapeutics advanced cell therapy"
			16:45 - 17:20	Panel discussion: Who to finance Cell based start-ups?: VC, public, private, pharma and biotech perspectives Moderator: Zami Aberman, CEO Pluristem Therapeutics Inc. Participants: Prof. Steven E. Cohen, MD, Daiichi Sankyo, Inc. Jane Andrews, PhD, Senior Consultant, Transformational Health & Lifesciences, North America Frost & Sullivan Jim Knight, BioTime, Inc. Nurit Tweezer-Zaks, Sanofi
			17:20 - 17:50	Interactive Discussion: The promise of regenerative medicine and the challenges facing the field

	THURSDAY, MAY 25, 2017
08:30 – 15:00	Registration Open
09:00 - 09:20	Aharon Aharon, ‎CEO Israel Innovation Authority
09:20 - 10:00	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine: "The genetic underline of exceptional longevity–drug development"
10:00 – 10:40	Lloyd Klickstein MD, PhD, Head of Translational Medicine, New Indications Discovery Unit at Novartis Institutes for BioMedical Research, Novartis: "The Promise of New Approaches for Aging"
10:40 - 11:15	Prof. Junxia Min, MD, PhD, Zhejiang University, China: "Challenges and promises of aging trajectory in China"
11:15 – 11:35	Coffee Break
	AGE RELATED DISEASES HALL A		LONGEVITY: GENETICS AND EPIGENETICS HALL B		TTO: WORK IN PROCESS IN THE ACADEMIA HALL C
	CARDIOLOGY		Symposium Chairperson: Prof. Nir Barzilai, MD, Albert Einstein College of Medicine:		Symposium Chairperson: Gil Granot-Mayer, Yeda Research & Development Co. Ltd.
	Cardiology Chairperson: Prof. Amir Lerman, MD, Mayo Clinic		11:35 - 11:55	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine:	11:35 - 11:45	Gil Granot-Mayer, Yeda Research & Development Co. Ltd. "Introduction"
	11:35 - 11:55	Prof. Amir Lerman, MD, Mayo Clinic: "Opportunities in cardiovascular aging"	11:55 - 12:10	Natalie Yivgi Ohana, Minovia Therapeutics: "Mitochondrial Therapy and Age-Related Diseases"	11:45 - 12:00	Dr. Eyal Zimlichman, Sheba Medical Center Hospital: “Big data and digital health solutions for aging related issues”
	11:55 - 12:15	Prof. Haim Danenberg, MD, Hadassah Medical Center: "The revolution and evolution of transcatheter therapy of structural heart disease"	12:10 - 12:25	Yona Keisari, Alpha Tau Medical LTD.: "Alpha DaRT: A Novel Effective and Safe Alpha Radiation Based Radiotherapy"	12:00 - 12:15	Prof. Tamir Ben Hur, Hadassah Jerusalem Medical Center: "A clinical and translational view of Alzheimer’s disease therapeutics"
	12:15 - 12:30	Daniel Weiss, Enopace Biomedical: "Aortic Stimulation for Neuromodulation of Heart Failure"	12:25 - 12:40	Ilia Stambler, Comorbidity Detection Technologies - CD Technologies Ltd: "The Quantified Longevity Guide - QLG"	12:15 - 12:30	Prof. Michal Schwartz, Weizmann Institute: "The potential of immune checkpoint blockade for fighting against Alzheimer's disease"
	12:30 - 12:50	Prof. Rafi Beyar, MD, PhD, Rambam Medical Center: "Robots getting into your heart"	12:40 - 13:10	Prof. Steven N. Austad, PhD, University of Alabama: "Aging has a biology that can be targeted!- pre clinical data and repurposing of drugs"	12:30 - 12:45	Prof. Valery Krizhanovsky, Weizmann Institute: “Directed elimination of senescent cells for targeting of age-related diseases”
	OPHTHALMOLOGY		13:10 - 13:40	Prof. James L Kirkland, MD, PhD, Mayo Clinic: "Targeting Senescent Cells: The Path to Translation"	12:45 - 13:00	Prof. Ehud Cohen, The Hebrew University of Jerusalem: "From a single disease to a complex syndrome – the challenge of Alzheimer’s disease and novel research strategies"
	12:50 - 13:10	Prof. Anat Loewenstein, MD, Tel Aviv Medical Center: "Diagnosis and Treatment of Age Related Macular Degeneration (AMD) in 2017 and Beyond"			13:00 - 13:15	Prof. Tal Dvir, Tel-Aviv University: "Engineering Organs and Body Parts"
	13:10 - 13:25	Yaakov Milstain, Nano Retina: "BioRetina"			13:15 - 13:40	Questions and Answers
	13:25 - 13:40	Nahum Ferera, EyeYon Medical: "Innovative solutions for corneal healing"
13:40 - 14:55	Lunch Break
	ONCOLOGY		14:55 - 15:15	Prof. Haim Cohen, PhD, Bar-Ilan University: "Moses: A mouse model for health and longevity-drug development (Sirt6-Moses)"	TTO: COMPANIES FROM THE ACADEMIA HALL C
	14:55 -15:25	Rachel W. Humphrey, MD, SVP, Chief Medical Officer, CytomX Therapeutics: "New Frontiers in Immuno-oncology Treatments - Challenges and Opportunities"	15:15 - 15:30	Boaz Brill, GluSense Ltd.: "GluSense Glyde CGM - a long-term implantable glucose sensor"	Moderator: Dr. Shay Sela, Yeda Research & Development Co. Ltd.
	15:25 - 15:45	Prof. Dror Harats, MD, CEO, VBL Therapeutics: "Viral Immune Oncology"	15:30 - 15:45	Lihi Segal, DayTwo: "Balancing Blood Glucose Levels using Gut Microbiome"	14:55 - 15:15	Dr. Andy Levy, BioRap Technologies LTD: “Prediction and Prevention of Diabetes-Related Complications- from academia to market”
	15:45 - 16:00	Tsipi Keren-Lehrer, Compugen: "From Code to Cure: Predictive Discovery of Novel Immune Checkpoints"	15:45 - 16:00	Yael Glassman, Nutrino Health Ltd.: "Personalized Nutrition in Diabetes - Food as Medicine"	15:15 - 15:30	Dr. Arnon Karni, Tel Aviv Medical Center "Induction of repair by oligodendrogenesis and neurogenesis in immune mediated diseases of central nervous system"
	16:00 - 16:15	David Malek, BioLineRx: "BioLineRx developing novel treatments which could improve the activity of cancer immunotherapy"	16:00 - 16:15	Nadav Kidron, Oramed Pharmaceuticals: "Oramed Pharmaceuticals: Oral insulin and the future of diabetes care"	15:30 - 15:45	Dr. Jonathan Solomon, NeuroPhage Pharmaceutical: "ProClara / NeuroPhage - A singular approach to protein misfolding diseases"
	16:15 - 16:30	Oren M. Becker, ViDAC Pharma: "Novel metabolic immuno-oncology drugs for skin cancer and solid tumors"	16:15 - 17:00	Panel: Discussion & Conclusion Moderator: Prof. Nir Barzilai, MD, Albert Einstein College of Medicine	15:45 - 16:00	Mr. Moshe Weinstein, Moebius Medical Ltd.: “A novel and sustainable pain relief treatment for osteoarthritis”
	16:30 - 16:45	Offer Fabian, Musli Thyropeutics Ltd.: "Cancer and thyroid - a novel Oncological approach"			16:00 - 16:15	Dr. Eti Yoles, Immunobrain Checkpoint Ltd: “Treatment of Alzheimer's disease”
	16:45 - 17:45	Panel: Discussion & Conclusion			16:15 - 16:30	Mr. Eyal Gura, Zebra Technologies: “Early detection of Osteoporosis”
					16:30 - 16:45	Prof. Zeev Zalevsky, ContinUse Biometrics Ltd.: “Remote & contactless bio-sensing”
					16:45 - 17:00	Dr. Edi Barkai, Memoboost Ltd.: "Drug Development for Cognitive Enhancement"